Feldan

Company Details

  • Business Type : Manufacturer
  • Location : Qu筌�옙ec
  • Year Established : 2002
  • Number Of Employees : 11 - 50
  • Export Percentage :
  • Production Lines :
  • R&D Staff :
  • Total Annual Revenue :
  • Main Products : Growth Factors,Chemokines,Cytokines,Antibodies,Antigens,Biology Molecular,
  • Country/Region : Canada
  • Links : Canada Chemicals, Canada Pharmaceutical Chemicals,
  • Company Introduction

    Our Mission: Improve people's health by delivering optimal access to high quality Biopharmaceuticals at competitive price.Our Vision: To be a world leading provider of innovative Research & Therapeutic proteins. About us: Feldan Bio develops, manufactures and distributes high quality recombinant Biopharmaceuticals at competitive price. Over the years, Feldan Bio has developed one of the world's largest range of proteins including, E. coli, insect, and mammalian cell-derived recombinant proteins. Our extensive product line includes Cytokines, Growth Factors, Chemokines, Enzymes, Antibodies, Viral Antigens, Hormones, Toxins, Receptors and Feldan Bio筌�옙占썲㎤占�proprietary developed technologies provide an edge over the competition due to lower production costs, high yields and production efficiencies. We thrive for quality, which is the essential factor in achieving a favourable position in the market place and the benefits associated with manufacturing top quality products. Every batch we produce is strictly tested to meet the requirements of clinical grade Biopharmaceuticals.Feldan Bio provides: Research Proteins to basic research, clinical research, and clinical diagnostic markets around the world with Recombinant Research Proteins for cancer, development, endocrinology, immunology, neuroscience, proteases, and stem cell research. Feldan Bio provides a comprehensive range of top cGMP generic Therapeutic Proteins Therapeutic Proteins that are the generic equivalent of brand Biopharmaceuticals that no longer enjoy patent protection.Full Technology Transfer: Feldan Bio offers Full Technology Transfer of its Technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases including cancer, diabetes, hepatitis or multiple sclerosis.

    Company Information

  • Contact Person : Jean-Philippe Michaud
  • Job Title : General Manager
  • Telephone :
  • Fax Number :
  • Address : 4975 Rideau, Suite 100 Qu筌�옙ec, Qu筌�옙ec
  • Fax : 877 - 956 - 7709
  • Website : Visit website
  • Company Product

    • R. Human Granulocyte Macrophage-Colony Stimulating Factor
    • Recombinant Human Erythropoietin-alpha
    • Recombinant Human Insulin Like Growth Factor-I
    • Recombinant Human Interferon-gamma
    • Recombinant Human WNT-1